Product
Supplier
Encyclopedia
Inquiry
Tideglusib 98%+ buy - large image1
Tideglusib 98%+ buy - image1

Tideglusib 98%+

9 Inquiries

Unit Price: Get Latest Price
CAS No.:

865854-05-3

Content:

98%

Port:

上海

Packaging:

1kg/bag

Price valid (until):

2025-05-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Dicobalt Octacarbonyl,(E,E)-Farnesol,(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one,Geranyl linalool

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione Chemical Properties
    Melting point  148 - 150oC
    Boiling point  511.3±43.0 °C(Predicted)
    density  1.393
    storage temp.  2-8°C
    solubility  DMSO: >15mg/mL
    pka -1.51±0.20(Predicted)
    form  powder
    color  white to beige
    InChI InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2
    InChIKey PMJIHLSCWIDGMD-UHFFFAOYSA-N
    SMILES S1C(=O)N(CC2=CC=CC=C2)C(=O)N1C1=C2C(C=CC=C2)=CC=C1

     

    4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione Usage And Synthesis
    Uses Tideglusib is used in the treatment of brain atrophy, and movement disorder issues.
    Uses Tideglusib has been used:
    • as a reference compound in ADP-GloTM Kinase assay
    • as an allosteric inhibitor of GSK-3β to study its effects on myocardial remodeling and angiogenesis
    • as a differentiation agent (specifically a glycogen synthase kinase (GSK)-3β inhibitor) to convert fibroblast cells into octamer-binding transcription factor-4 (OCT4)+ and vascular endothelial growth factor receptor-2 (VEGFR-2/fetal liver kinase-1 (FLK1)+ cells

    Application Tideglusib is used in the treatment of brain atrophy, and movement disorder issues.
    As a reagent, Tideglusib has been used:
    as a reference compound in ADP-GloTM Kinase assay
    as an allosteric inhibitor of GSK-3β to study its effects on myocardial remodeling and angiogenesis
    as a differentiation agent (specifically a glycogen synthase kinase (GSK)-3β inhibitor) to convert fibroblast cells into octamer-binding transcription factor-4 (OCT4)+ and vascular endothelial growth factor receptor-2 (VEGFR-2/fetal liver kinase-1 (FLK1)+ cells.


    Pls input...

    Items Specifications






    Basic Info
    Product Name:

    Tideglusib

    Other Name:

    1,2,4-Thiadiazolidine-3,5-dione,2-(1-naphthalenyl)-4-(phenylmethyl)-;2-(1-Naphthalenyl)-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione;4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione;Tideglusib;NP 12;NP 031112;945421-01-2;1073650-08-4

    CAS No.:

    865854-05-3

    Molecular Formula:

    C19H14N2O2S

    InChIKeys:

    InChIKey=PMJIHLSCWIDGMD-UHFFFAOYSA-N

    Molecular Weight:

    334.39166

    Exact Mass:

    334.39

    UNII:

    Q747Y6TT42

    DSSTox ID:

    DTXSID90235682

    Characteristics
    PSA:

    65.9

    XLogP3:

    4.3

    Appearance:

    white to beige

    Density:

    1.4±0.1 g/cm3

    Melting Point:

    148-150ºC

    Boiling Point:

    511.3ºC at 760 mmHg

    Flash Point:

    263.0±28.2 °C

    Refractive Index:

    1.735

    Water Solubility:

    Sparingly soluble with water.DMSO: >15mg/mL

    Storage Conditions:

    2-8°C

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Dicobalt Octacarbonyl,(E,E)-Farnesol,(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one,Geranyl linalool

    Location:

    11F ,#20 building, #18 Fuquan Road ,Jiangbei District, CHONGQING 400020, P.R China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    350

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    11-50

    Year of Establishment:

    2010

  • Inquiry History
    9 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    High Purity Tideglusib 99% Powder CAS 865854-05-3 EGC-Tideglusib Powder

    1 MT Oct 31, 2023
    United States

    Tideglusib

    25 G Jun 13, 2026
    Spain

    Tideglusib

    1 KG Mar 29, 2025
    United Kingdom

    Tideglusib

    25 G Jun 8, 2026
    United States

    Tideglusib

    10 G Apr 25, 2024
    United States

    Tideglusib

    100 MG Apr 16, 2024
    Russia

    Tideglusib

    0.1 KG Jan 26, 2025
    United States

    Tideglusib

    100 MG Apr 17, 2024
    Slovenia

    Tideglusib

    1 KG Mar 20, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.